VaxGen and EndoBiologics Form Collaboration

VaxGen and EndoBiologics International announced that they have formed a collaboration to pursue research of a vaccine against Meningitis serogroup B, using technology developed by EndoBiologics. VaxGen intends to fund proof-of-concept studies during the next 12 months and has an exclusive option to continue product development if the studies yield promising results.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19933820&full=1)